(Q47912506)

6 February 2018

review article

1 reference

title

Cytokines and chemokines in HIV infection: implications for therapy (English)

1 reference

6 February 2018

author name string

Emilie D

series ordinal

1

1 reference

6 February 2018

Galanaud P

series ordinal

2

1 reference

6 February 2018

publication date

1 January 1998

1 reference

6 February 2018

International Reviews of Immunology

published in

1 reference

6 February 2018

volume

16

1 reference

6 February 2018

issue

5-6

1 reference

6 February 2018

page(s)

705-726

1 reference

6 February 2018

Serum levels of tumor necrosis factor-alpha (TNF alpha) and soluble TNF receptors in human immunodeficiency virus type 1 infection--correlations to clinical, immunologic, and virologic parameters

cites work

1 reference

https://api.crossref.org/works/10.3109%2F08830189809043015

Production of interleukins in human immunodeficiency virus-1-replicating lymph nodes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189809043015

IL-10 inhibits HIV-1 replication and is induced by tat.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189809043015

Recombinant gp120 induces IL-10 in resting peripheral blood mononuclear cells; correlation with the induction of other cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189809043015

Cytokines from lymphoid organs of HIV-infected patients: production and role in the immune disequilibrium of the disease and in the development of B lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189809043015

Cytokines from lymphoid organs of HIV-infected patients: production and role in the immune disequilibrium of the disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189809043015

Soluble receptors for tumor necrosis factor as predictors of progression to AIDS in asymptomatic human immunodeficiency virus type 1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189809043015

Soluble tumor necrosis factor-alpha receptor type II (sTNF alpha RII) correlates with human immunodeficiency virus (HIV) RNA copy number in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189809043015

Impaired interleukin 12 production in human immunodeficiency virus-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189809043015

Molecular analysis of decreased interleukin-12 production in persons infected with human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189809043015

Changes in interleukin-2 and interleukin-4 production in asymptomatic, human immunodeficiency virus-seropositive individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189809043015

T-cell dysfunction in HIV infection: anergy due to defective antigen-presenting cell function?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189809043015

Human immunodeficiency virus-1 glycoproteins gp120 and gp160 specifically inhibit the CD3/T cell-antigen receptor phosphoinositide transduction pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189809043015

Human immunodeficiency virus gp120 and derived peptides activate protein tyrosine kinase p56lck in human CD4 T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189809043015

Increases in CD4 T lymphocytes with intermittent courses of interleukin-2 in patients with human immunodeficiency virus infection. A preliminary study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189809043015

Efficacy of low doses of the polyethylene glycol derivative of interleukin-2 in modulating the immune response of patients with human immunodeficiency virus type 1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189809043015

Prolonged immunostimulatory effect of low-dose polyethylene glycol interleukin 2 in patients with human immunodeficiency virus type 1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189809043015

Controlled trial of interleukin-2 infusions in patients infected with the human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189809043015

Rational interleukin 2 therapy for HIV positive individuals: daily low doses enhance immune function without toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189809043015

A TH1-->TH2 switch is a critical step in the etiology of HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189809043015

Role of TH1/TH2 cytokines in HIV infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189809043015

Natural killer (NK) cell stimulatory factor increases the cytotoxic activity of NK cells from both healthy donors and human immunodeficiency virus-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189809043015

In vitro effect of interleukin-12 on antigen-specific lymphocyte proliferative responses from persons infected with human immunodeficiency virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189809043015

In vitro restoration of T cell immune function in human immunodeficiency virus-positive persons: effects of interleukin (IL)-12 and anti-IL-10.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189809043015

Modulation of T cell responses to recall antigens presented by Langerhans cells in HIV-discordant identical twins by anti-interleukin (IL)-10 antibodies and IL-12

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189809043015

Role of interleukin-10 in T helper cell dysfunction in asymptomatic individuals infected with the human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189809043015

T cell cytokine responses in persons with tuberculosis and human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189809043015

Delayed-type hypersensitivity skin testing predicts progression to AIDS in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189809043015

Human immunodeficiency virus infection in the US Air Force: seroconversions, clinical staging, and assessment of a T helper cell functional assay to predict change in CD4+ T cell counts

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189809043015

Lack of T cell dysfunction and programmed cell death in human immunodeficiency virus type 1-infected chimpanzees correlates with absence of monocytotropic variants

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189809043015

Rapid loss of CD4+ T cells in human-PBL-SCID mice by noncytopathic HIV isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189809043015

Type 1/type 2 cytokine modulation of T-cell programmed cell death as a model for human immunodeficiency virus pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189809043015

T helper type 1/T helper type 2 cytokines and T cell death: preventive effect of interleukin 12 on activation-induced and CD95 (FAS/APO-1)-mediated apoptosis of CD4+ T cells from human immunodeficiency virus-infected persons

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189809043015

Th2-like CD8+ T cells showing B cell helper function and reduced cytolytic activity in human immunodeficiency virus type 1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189809043015

A randomized, double-blind, phase I/II trial of tumor necrosis factor and interferon-gamma for treatment of AIDS-related complex (Protocol 025 from the AIDS Clinical Trials Group).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189809043015

Inhibition of immunoreactive tumor necrosis factor-alpha by a chimeric antibody in patients infected with human immunodeficiency virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189809043015

CD8+ T cells suppress human immunodeficiency virus replication by inhibiting viral transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189809043015

Interleukin 2 induces CD8+ T cell-mediated suppression of human immunodeficiency virus replication in CD4+ T cells and this effect overrides its ability to stimulate virus expression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189809043015

Effects of TH1 and TH2 cytokines on CD8+ cell response against human immunodeficiency virus: implications for long-term survival

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189809043015

HIV suppression by interleukin-16.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189809043015

Interleukin 16 and its function as a CD4 ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189809043015

HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189809043015

The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189809043015

The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189809043015

Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189809043015

CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189809043015

The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189809043015

Identification of a major co-receptor for primary isolates of HIV-1

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189809043015

HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189809043015

A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189809043015

Regions in beta-chemokine receptors CCR5 and CCR2b that determine HIV-1 cofactor specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189809043015

Infection by human immunodeficiency virus--CD4 is not enough

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189809043015

CD4-independent infection by HIV-2 is mediated by fusin/CXCR4.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189809043015

Human immunodeficiency virus type 1 infection alters chemokine beta peptide expression in human monocytes: implications for recruitment of leukocytes into brain and lymph nodes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189809043015

Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189809043015

Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189809043015

Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189809043015

Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the CKR5 Structural Gene

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189809043015

Restoration of HIV-specific cell-mediated immune responses by interleukin-12 in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189809043015

Intrathecal synthesis of interleukin-10 (IL-10) in viral and inflammatory diseases of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189809043015

HIV-1 subtype and second-receptor use

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189809043015

HIV blocked by chemokine antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189809043015

10.3109/08830189809043015

21 January 2018

Identifiers

DOI

1 reference

6 February 2018

1 reference

6 February 2018